Comments
Loading...
ImmuCell Analyst Ratings and Price Targets | NASDAQ:ICCC | Benzinga
ImmuCell Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for ImmuCell Corp from these most-recent analyst ratings.
Analyst Ratings for ImmuCell
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for ImmuCell (ICCC) stock?
There is no price target for ImmuCell
What is the most recent analyst rating for ImmuCell (ICCC)?
There is no analyst for ImmuCell
When was the last upgrade for ImmuCell (ICCC)?
There is no last upgrade for ImmuCell
When was the last downgrade for ImmuCell (ICCC)?
There is no last downgrade for ImmuCell.
When is the next analyst rating going to be posted or updated for ImmuCell (ICCC)?
There is no next analyst rating for ImmuCell.
Is the Analyst Rating ImmuCell (ICCC) correct?
There is no next analyst rating for ImmuCell.
Browse analyst ratings and price targets on all stocks.